178 related articles for article (PubMed ID: 31426484)
1. H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer.
Bacci L; Aiello A; Ripoli C; Loria R; Pugliese D; Pierconti F; Rotili D; Strigari L; Pinto F; Bassi PF; Mai A; Grassi C; Pontecorvi A; Falcioni R; Farsetti A; Nanni S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426484
[TBL] [Abstract][Full Text] [Related]
2. Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer.
Pecci V; Troisi F; Aiello A; De Martino S; Carlino A; Fiorentino V; Ripoli C; Rotili D; Pierconti F; Martini M; Porru M; Pinto F; Mai A; Bassi PF; Grassi C; Gaetano C; Pontecorvi A; Strigari L; Farsetti A; Nanni S
Cancer Cell Int; 2024 Feb; 24(1):56. PubMed ID: 38317193
[TBL] [Abstract][Full Text] [Related]
3. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
Pal M
J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
[TBL] [Abstract][Full Text] [Related]
4. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract][Full Text] [Related]
5. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
6. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
[TBL] [Abstract][Full Text] [Related]
7. Long Non Coding RNA H19: A New Player in Hypoxia-Induced Multiple Myeloma Cell Dissemination.
Corrado C; Costa V; Giavaresi G; Calabrese A; Conigliaro A; Alessandro R
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781795
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
9. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the ITGB4 gene in prostate cancer.
Wilkinson EJ; Woodworth AM; Parker M; Phillips JL; Malley RC; Dickinson JL; Holloway AF
Exp Cell Res; 2020 Jul; 392(2):112055. PubMed ID: 32376286
[TBL] [Abstract][Full Text] [Related]
11. H19 regulates trophoblastic spheroid adhesion by competitively binding to let-7.
He D; Zeng H; Chen J; Xiao L; Zhao Y; Liu N
Reproduction; 2019 May; 157(5):423-430. PubMed ID: 30780128
[TBL] [Abstract][Full Text] [Related]
12. Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion.
Wang L; Sun Y; Yi J; Wang X; Liang J; Pan Z; Li L; Jiang G
Exp Lung Res; 2016 Sep; 42(7):346-353. PubMed ID: 27607135
[TBL] [Abstract][Full Text] [Related]
13. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract][Full Text] [Related]
14. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
15. Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer.
Eke I; Makinde AY; Aryankalayil MJ; Reedy JL; Citrin DE; Chopra S; Ahmed MM; Coleman CN
Mol Cancer Res; 2018 Dec; 16(12):1855-1864. PubMed ID: 30042176
[TBL] [Abstract][Full Text] [Related]
16. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b.
Zhou W; Ye XL; Xu J; Cao MG; Fang ZY; Li LY; Guan GH; Liu Q; Qian YH; Xie D
Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611183
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
[TBL] [Abstract][Full Text] [Related]
19. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
20. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
